Visionary Wealth Advisors Rigel Pharmaceuticals Inc Transaction History

Visionary Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.82 $9,823 - $15,963	8,771 Added 64.85%	22,297 $28,000
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $16,907 - $27,052	13,526 New	13,526 $17,000
Q1 2022 May 12, 2022	SELL	$2.22 - $3.45 $24,233 - $37,660	-10,916 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $590 - $892	-250 Reduced 2.24%	10,916 $29,000
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $1,844 - $2,371	-527 Reduced 4.51%	11,166 $41,000
Q2 2021 Aug 13, 2021	BUY	$3.09 - $4.54 $36,131 - $53,086	11,693 New	11,693 $51,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Visionary Wealth Advisors with notifications on news.